MYGN r&d expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Myriad Genetics Inc R&D Expenses — Trailing twelve months (TTM) (USD)
Period ending	R&D Expenses (USD)
Jun 30, 2026	105,800,000
Mar 31, 2026	106,400,000
Dec 31, 2025	106,800,000
Sep 30, 2025	113,500,000
Jun 30, 2025	113,800,000
Mar 31, 2025	115,300,000
Dec 31, 2024	112,700,000
Sep 30, 2024	101,500,000
Jun 30, 2024	97,000,000
Mar 31, 2024	91,100,000
Dec 31, 2023	88,700,000
Sep 30, 2023	91,100,000
Jun 30, 2023	87,600,000
Mar 31, 2023	86,700,000
Dec 31, 2022	85,400,000
Sep 30, 2022	82,500,000
Jun 30, 2022	80,800,000
Mar 31, 2022	80,000,000
Dec 31, 2021	81,900,000
Sep 30, 2021	61,400,000
Jun 30, 2021	60,200,000
Mar 31, 2021	58,100,000
Dec 31, 2020	54,700,000
Sep 30, 2020	73,500,000
Jun 30, 2020	77,200,000
Mar 31, 2020	80,700,000
Dec 31, 2019	82,500,000
Sep 30, 2019	86,100,000
Jun 30, 2019	85,900,000
Mar 31, 2019	82,700,000
Dec 31, 2018	79,700,000
Sep 30, 2018	74,100,000
Jun 30, 2018	70,800,000
Mar 31, 2018	71,900,000
Dec 31, 2017	71,000,000
Sep 30, 2017	72,800,000
Jun 30, 2017	74,400,000
Mar 31, 2017	75,100,000
Dec 31, 2016	74,700,000
Sep 30, 2016	72,800,000
Jun 30, 2016	70,600,000
Mar 31, 2016	69,800,000
Dec 31, 2015	69,273,000
Sep 30, 2015	70,077,000
Jun 30, 2015	75,489,000
Mar 31, 2015	76,976,000
Dec 31, 2014	73,700,000
Sep 30, 2014	73,286,000
Jun 30, 2014	67,477,000
Mar 31, 2014	61,871,000
Dec 31, 2013	62,092,000
Sep 30, 2013	59,109,000
Jun 30, 2013	53,706,000
Mar 31, 2013	51,269,000
Dec 31, 2012	49,404,000
Sep 30, 2012	45,540,000
Jun 30, 2012	42,645,000
Mar 31, 2012	39,732,000
Dec 31, 2011	34,646,000
Sep 30, 2011	30,495,000
Jun 30, 2011	27,752,000
Mar 31, 2011	23,774,000
Dec 31, 2010	22,992,000
Sep 30, 2010	21,959,000
Jun 30, 2010	21,873,000
Mar 31, 2010	-20,416,000
Dec 31, 2009	-8,451,000
Sep 30, 2009	6,442,000
Jun 30, 2009	17,915,000
Mar 31, 2009	110,176,000
Dec 31, 2008	123,487,000
Sep 30, 2008	130,841,000
Jun 30, 2008	139,717,000
Mar 31, 2008	110,667,000
Dec 31, 2007	102,924,000
Sep 30, 2007	100,382,000
Jun 30, 2007	100,709,000
Mar 31, 2007	98,828,000
Dec 31, 2006	97,377,000
Sep 30, 2006	91,643,000
Jun 30, 2006	83,757,000
Mar 31, 2006	75,488,000
Dec 31, 2005	69,061,000
Sep 30, 2005	64,577,000
Jun 30, 2005	59,243,000
Mar 31, 2005	55,222,000
Dec 31, 2004	52,072,000
Sep 30, 2004	49,084,000
Jun 30, 2004	48,926,000
Mar 31, 2004	50,294,000
Dec 31, 2003	48,957,000
Sep 30, 2003	49,617,000
Jun 30, 2003	47,589,000
Mar 31, 2003	44,897,968
Dec 31, 2002	42,584,920
Sep 30, 2002	38,979,308
Jun 30, 2002	36,294,668
Mar 31, 2002	32,861,608
Dec 31, 2001	32,550,058
Sep 30, 2001	33,288,706